| Proteome‐based classification of nonmuscle invasive bladder cancer R Stroggilos, M Mokou, A Latosinska, M Makridakis, V Lygirou, ... International Journal of Cancer 146 (1), 281-294, 2020 | 37 | 2020 |
| A novel urinary proteomics classifier for non-invasive evaluation of interstitial fibrosis and tubular atrophy in chronic kidney disease L Catanese, J Siwy, E Mavrogeorgis, K Amann, H Mischak, J Beige, ... Proteomes 9 (3), 32, 2021 | 30 | 2021 |
| Reproducibility evaluation of urinary peptide detection using CE-MS E Mavrogeorgis, H Mischak, A Latosinska, J Siwy, V Jankowski, ... Molecules 26 (23), 7260, 2021 | 29 | 2021 |
| Collagen-derived peptides in CKD: a link to fibrosis E Mavrogeorgis, H Mischak, A Latosinska, A Vlahou, JP Schanstra, J Siwy, ... Toxins 14 (1), 10, 2021 | 17 | 2021 |
| Understanding glomerular diseases through proteomics E Mavrogeorgis, H Mischak, J Beige, A Latosinska, J Siwy Expert Review of Proteomics 18 (2), 137-157, 2021 | 7 | 2021 |
| Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease E Mavrogeorgis, T He, H Mischak, A Latosinska, A Vlahou, JP Schanstra, ... Nephrology Dialysis Transplantation 39 (3), 453-462, 2024 | 4 | 2024 |
| Gene expression monotonicity across bladder cancer stages informs on the molecular pathogenesis and identifies a prognostic eight-gene signature R Stroggilos, M Frantzi, J Zoidakis, M Mokou, N Moulavasilis, ... Cancers 14 (10), 2542, 2022 | 4 | 2022 |
| Urinary peptide analysis to predict the response to blood pressure medication MA Jaimes Campos, E Mavrogeorgis, A Latosinska, S Eder, ... Nephrology Dialysis Transplantation, gfad223, 2023 | 1 | 2023 |
| Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD S Hobson, E Mavrogeorgis, T He, J Siwy, T Ebert, K Kublickiene, ... Proteomes 11 (3), 25, 2023 | 1 | 2023 |
| Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension L Lauder, J Siwy, E Mavrogeorgis, F Keller, M Kunz, A Wachter, I Emrich, ... Hypertension, 2024 | | 2024 |
| Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease E Mavrogeorgis, S Valkenburg, J Siwy, A Latosinska, G Glorieux, ... Proteomes 12 (2), 11, 2024 | | 2024 |
| Multiple urinary peptides display distinct sex‐specific distribution IK Mina, E Mavrogeorgis, J Siwy, R Stojanov, H Mischak, A Latosinska, ... Proteomics 24 (5), 2300227, 2024 | | 2024 |
| Validation of a urine-based proteomics test to predict clinically significant prostate cancer: complementing MRI pathway M Frantzi, AC Morillo, G Lendinez, A Blanca-Pedregosa, D Lopez Ruiz, ... medRxiv, 2024.04. 16.24305475, 2024 | | 2024 |
| Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment S Lohia, J Siwy, E Mavrogeorgis, S Eder, S Thöni, G Mayer, H Mischak, ... International Journal of Molecular Sciences 24 (17), 13540, 2023 | | 2023 |
| Association of urinary peptides with hypertension E Mavrogeorgis, M Kondyli, H Mischak, A Vlahou, J Siwy, P Rossing, ... medRxiv, 2023.12. 14.23299991, 2023 | | 2023 |
| Uniform Manifold Approximation and Projection-based Assessment of Chronic Kidney Disease Aetiologies based on Urinary Peptidomics E Mavrogeorgis, T He, H Mischak, A Latosinska, A Vlahou, JP Schanstra, ... medRxiv, 2023.05. 19.23290228, 2023 | | 2023 |
| Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients S Lohia, J Siwy, E Mavrogeorgis, S Eder, S Thoeni, G Mayer, H Mischak, ... medRxiv, 2023.05. 03.23289439, 2023 | | 2023 |
| Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature. Cancers 2022, 14, 2542 R Stroggilos, M Frantzi, J Zoidakis, M Mokou, N Moulavasilis, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Gene expression and coexpression analysis of the entire bladder cancer clinical stage spectrum R Stroggilos, M Frantzi, J Zoidakis, E Mavrogeorgis, M Mokou, A Melidi, ... European Urology Open Science 32, S180, 2021 | | 2021 |
| Gene expression and coexpression alterations marking evolution of bladder cancer R Stroggilos, M Frantzi, J Zoidakis, E Mavrogeorgis, M Mokou, ... medRxiv, 2021.06. 15.21258890, 2021 | | 2021 |
